These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2578626)

  • 1. Interferons and oncogenes.
    Clemens M
    Nature; 1985 Feb 14-20; 313(6003):531-2. PubMed ID: 2578626
    [No Abstract]   [Full Text] [Related]  

  • 2. Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene.
    Samid D; Chang EH; Friedman RM
    Biochem Biophys Res Commun; 1984 Feb; 119(1):21-8. PubMed ID: 6200112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of c-myc expression by IFN: further analysis of the sensitive and the resistant phenotype of cells.
    Kimchi A; Yarden A; Gat G; Resnitzky D
    Prog Clin Biol Res; 1985; 202():195-202. PubMed ID: 2421303
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of protein phosphatases in malignant transformation.
    Nagao M; Sakai R; Kitagawa Y; Ikeda I; Sasaki K; Shima H; Sugimura T
    Princess Takamatsu Symp; 1989; 20():177-84. PubMed ID: 2562181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-mediated regulation of myc and Ki-ras oncogene expression in long-term-treated murine viral transformed cells.
    Emanoil-Ravier R; Pochart F; Canivet M; Garcette M; Tobaly-Tapiero J; Peries J
    J Interferon Res; 1985; 5(4):613-9. PubMed ID: 2418130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.
    Stacey DW; Kung HF
    Nature; 1984 Aug 9-15; 310(5977):508-11. PubMed ID: 6611509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identification of LRF as an oncogene that bypasses RASV12-induced senescence via upregulation of CYCLIN E.
    Vredeveld LC; Rowland BD; Douma S; Bernards R; Peeper DS
    Carcinogenesis; 2010 Feb; 31(2):201-7. PubMed ID: 19942610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cellular oncogenes in human prostatic carcinoma cell lines.
    Rijnders AW; van der Korput JA; van Steenbrugge GJ; Romijn JC; Trapman J
    Biochem Biophys Res Commun; 1985 Oct; 132(2):548-54. PubMed ID: 3904752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer: mutant ras proteins and cell transformation.
    Newbold R
    Nature; 1984 Aug 23-29; 310(5979):628-9. PubMed ID: 6382018
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro and in vivo onco-suppressor activity of normal cells on cells transformed with the H-ras1 oncogene.
    Kakkanas A; Spandidos DA
    In Vivo; 1990; 4(2):109-14. PubMed ID: 2129801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of p21ras.GTP in response to stimulation with epidermal growth factor and oncogene products with tyrosine kinase activity.
    Satoh T; Endo M; Nakafuku M; Akiyama T; Yamamoto T; Kaziro Y
    Proc Natl Acad Sci U S A; 1990 Oct; 87(20):7926-9. PubMed ID: 2146678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Denervation of mouse skeletal muscle differentially affects the expression of the jun and fos proto-oncogenes.
    Bessereau JL; Fontaine B; Changeux JP
    New Biol; 1990 Apr; 2(4):375-83. PubMed ID: 2126956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers.
    Jacobs JJ; Keblusek P; Robanus-Maandag E; Kristel P; Lingbeek M; Nederlof PM; van Welsem T; van de Vijver MJ; Koh EY; Daley GQ; van Lohuizen M
    Nat Genet; 2000 Nov; 26(3):291-9. PubMed ID: 11062467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of ouabain on the anticellular and antiviral activities of human and mouse interferon.
    Kuwata T; Fuse A; Morinaga N
    J Gen Virol; 1977 Mar; 34(3):537-40. PubMed ID: 192839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of interferon on RNA, protein and polyribosome synthesis in murine L 1210 leukemia cells].
    Brouty-Boye D; Fiszman M; Macieira-Coelho A; Gresser I
    C R Acad Hebd Seances Acad Sci D; 1973 Mar; 276(11):1793-5. PubMed ID: 4202599
    [No Abstract]   [Full Text] [Related]  

  • 17. Regulation of C-myc and C-Ha-ras oncogene expression by cell shape.
    Farrell RE; Greene JJ
    J Cell Physiol; 1992 Nov; 153(2):429-35. PubMed ID: 1385453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of DNA synthesis of synchronized RSa cells by human leukocyte interferon.
    Fuse A; Kuwata T
    J Natl Cancer Inst; 1977 Apr; 58(4):891-6. PubMed ID: 845992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autocrine interferon and the suppression of the c-myc nuclear oncogene.
    Kimchi A
    Interferon; 1987; 8():85-110. PubMed ID: 2445690
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on the promoter region of the c-Ha-ras oncogene.
    Rapoport B; Damante G; Dere W; Filetti S
    Horm Metab Res Suppl; 1987; 17():57-62. PubMed ID: 2832303
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.